“Remember, he said he's looked at the lab results already.”

If you’ve run clinical trials before, then you understand that lab results must correlate with clinical improvement or they’re useless. So, the other outcomes, either primary or secondary, that aren’t labs, need to be analyzed. I’m not saying it will take a long time to analyze this data, but NP always under estimates deadlines, so mid-July for M2M data and maybe the same week for severe data seems plausible.